부산대학교 도서관

Monson KR; Ferguson R; Handzlik JE; Morales L; Xiong J; Chat V; Dagayev S; Khodadadi-Jamayran A; Simpson D; Kazlow E; Bunis A; Sreenivasaiah C; Ibrahim M; Voloshyna I; Ouwerkerk W; Luiten RM; Capone M; Madonna G; Lu Y; Shao Y; Pavlick A; Krogsgaard M; Mehnert J; Tang H; Dolfi S; Tenney D; Haanen JBAG; Gajewski TF; Hodi FS; Flaherty KT; Couts K; Robinson W; Puzanov I; Ernstoff MS; Rahma O; Postow M; Sullivan RJ; Luke JJ; Ascierto PA

Clin Cancer Res
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Consejo Superior de Investigaciones Científicas (CSIC)

Egeler MD; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. m.egeler@nki.nl.; Boomstra E; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Rohaan MW; Division of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Van den Heuvel NMJ; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Fraterman I; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Delfos M; Division of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; van de Poll-Franse LV; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Research & Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Department of Medical and Clinical Psychology, Center of Research on Psychology in Somatic Diseases (CoRPS), Tilburg University, Tilburg, The Netherlands.; Borch TH; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Svane IM; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Haanen JBAG; Division of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Retèl VP; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.; Boekhout AH; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 101307557 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1932-2267 (Electronic) Linking ISSN: 19322259 NLM ISO Abbreviation: J Cancer Surviv Subsets: MEDLINE

Anagnostopoulos, S; van Dongen, A; Aarts, MJB; van den Berkmortel, FWPJ; Blokx, WAM; Boers-Sonderen, MJ; van den Eertwegh, AJM; de Groot, JWB; Haanen, JBAG; Hospers, GAP; Kapiteijn, E; Suijkerbuijk, KPM; van der Veldt, AAM; Wouters, MWJM; Franken, M; Leeneman, B

Value in Health. 27(12):S153-S154

Breukers SE; Department of Head and Neck Surgery and Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. s.breukers@nki.nl.; Antoni Van Leeuwenhoek (NKI-AVL), The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. s.breukers@nki.nl.; Crommelin RD; Department of Head and Neck Surgery and Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Smit LA; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; de Boer JP; Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Navran A; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; van Houdt WJ; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; de Bree R; Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; Devriese LA; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; Haanen JBAG; Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Wondergem M; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Zuur CL; Department of Head and Neck Surgery and Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Otorhinolaryngology Head and Neck Surgery, Leiden University Medical Center, Leiden, The Netherlands.; Vogel WV; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. w.vogel@nki.nl.; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands. w.vogel@nki.nl.; Antoni Van Leeuwenhoek (NKI-AVL), The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. w.vogel@nki.nl.

Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE

A George; JBAG Haanen; E Mul; S Pack; S Ibáñez Molero; J Veldman; JJH Traets; K Hoefakker; L Tas; P Alóndiga-Mérida; B van den Broek; R Harkes; M Nieuwland; M van Baalen; S Tol; WJv Houdt; DS Peeper

Journal for ImmunoTherapy of Cancer, Vol 12, Iss Suppl 1 (2024)

Bloem, Manja; van Not, Olivier; Aarts, Maureen, MJB; van den Berkmortel FWPJ, Franchette; Blank CU, Christian; Blokx WAM, Willeke; Boers-Sonderen, Marije, MJB; Bonenkamp HJ, Han; Willem de Groot JWB, Jan; Haanen JBAG, John; Hospers GAP, Geke; Kapiteijn E, Ellen; Piersma D, Djura; van Rijn RS, Rozemarijn; Boer, Marion Stevense-de; van der Veldt A, Astrid; Art A, Vreugdenhil; van den Eertwegh AJM, Fons; Suijkerbuijk KPM, Karijn; Wouters MWJM, Michel

European Journal of Surgical Oncology. 50(2)

Lim, KHJ; Kamposioras, K; Élez, E; Haanen, JBAG; Hardy, C; Murali, K; O'Connor, M; Oing, C; Punie, K; de Azambuja, E; Blay, JY; Banerjee, S; ESMO Resilience Task Force

ESMO Open
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
Lim, K H J, Kamposioras, K, Élez, E, Haanen, J B A G, Hardy, C, Murali, K, O'Connor, M, Oing, C, Punie, K, de Azambuja, E, Blay, J Y & Banerjee, S 2024, 'ESMO Resilience Task Force recommendations to manage psychosocial risks, optimise well-being, and reduce burnout in oncology', ESMO Open, vol. 9, no. 10, pp. 103634. https://doi.org/10.1016/j.esmoop.2024.103634

Hoeijmakers LL; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Dimitriadis P; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Wijnen SCMA; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Reijers ILM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Lopez-Yurda M; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.; Broeks A; Core Facility Molecular Pathology & Biobanking Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital (NKI-AVL), Amsterdam, The Netherlands.; Cornelissen S; Core Facility Molecular Pathology & Biobanking Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital (NKI-AVL), Amsterdam, The Netherlands.; Torres Acosta A; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van der Wal A; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.; Versluis JM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van Houdt WJ; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Wouters MW; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.; Romano J; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Rozeman EA; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Grijpink-Ongering LG; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; van der Veldt AAM; Departments of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.; Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Eriksson H; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.; Unit of Head, Neck, Lung, and Skin Cancer/Skin Cancer Center, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.; Hospers GAP; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; van der Hage JA; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.; Grünhagen DJ; Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands.; Witkamp AJ; Department of Surgical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Lijnsvelt JM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Klop WMC; Department of Head and Neck Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Zuur CL; Department of Head and Neck Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Otorhinolaryngology Head and Neck Surgery, Leiden University Medical Center, Leiden, The Netherlands.; Bruining A; Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Al-Mamgani A; Department of Radiotherapy, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Radiation Oncology, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Pennington TE; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Shannon KF; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.; Ch'ng S; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Colebatch AJ; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Breast and Melanoma Surgery, Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.; Gonzalez M; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Spillane AJ; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.; Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.; Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Rawson RV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.; Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; van de Wiel BA; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van Akkooi ACJ; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; Blank CU; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. c.blank@nki.nl.; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands. c.blank@nki.nl.; Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands. c.blank@nki.nl.; Department of Hematology and Medical Oncology, University Clinic Regensburg, Regensburg, Germany. c.blank@nki.nl.; Division of Sarcoma and Melanoma, European Institute of Oncology, Milano, Italy. c.blank@nki.nl.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Ibáñez-Molero S; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Veldman J; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Simon Nieto J; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Traets JJH; Division of Tumor Biology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; George A; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Hoefakker K; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Karomi A; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Harkes R; BioImaging Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van den Broek B; BioImaging Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Pack SM; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Tas L; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Visser NL; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van Hal-van Veen SE; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Alóndiga-Mérida P; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Alkemade M; Core Facility Molecular Pathology & Biobanking, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Seignette IM; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Tissier R; Biostatistics Unit, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Nieuwland M; Genomic Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van Baalen M; Flow Cytometry Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Poźniak J; Laboratory for Molecular Cancer Biology, Department of Oncology, VIB Center for Cancer Biology, KU Leuven, Leuven, Belgium.; Mul E; Flow Cytometry Facility, Sanquin, Amsterdam, The Netherlands.; Tol S; Flow Cytometry Facility, Sanquin, Amsterdam, The Netherlands.; Stenqvist S; Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Nilsson LM; Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Harry Perkins Institute of Medical Research and University of Western Australia, Perth, Western Australia, Australia.; Nilsson JA; Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Harry Perkins Institute of Medical Research and University of Western Australia, Perth, Western Australia, Australia.; Haanen JBAG; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van Houdt WJ; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Peeper DS; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands. d.peeper@nki.nl.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

Bickley L; Specialist Centre for Kidney Cancer, Department of Urology, Royal Free London NHS Foundation Trust, London, UK.; Cancer Dynamics Laboratory, Francis Crick Institute, London, UK.; Fransen van de Putte EE; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van den Brink L; Department of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Imaging & Biomarkers, Cancer Centre Amsterdam, Amsterdam, The Netherlands.; Marandino L; Renal and Skin Units, Royal Marsden NHS Foundation Trust, London, UK.; van der Mijn JC; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Wilgenhof S; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van Thienen JV; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Boleti E; Specialist Centre for Kidney Cancer, Department of Medical Oncology, Royal Free London NHS Foundation Trust, London, UK.; Powles T; Specialist Centre for Kidney Cancer, Department of Medical Oncology, Royal Free London NHS Foundation Trust, London, UK.; Barts Cancer Institute, Queen Mary University, London, UK.; Zondervan PJ; Department of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Imaging & Biomarkers, Cancer Centre Amsterdam, Amsterdam, The Netherlands.; Graafland NM; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Renal Cancer Network, Amsterdam, The Netherlands.; Tippu Z; Cancer Dynamics Laboratory, Francis Crick Institute, London, UK.; Renal and Skin Units, Royal Marsden NHS Foundation Trust, London, UK.; Turajlic S; Cancer Dynamics Laboratory, Francis Crick Institute, London, UK.; Renal and Skin Units, Royal Marsden NHS Foundation Trust, London, UK.; Bex A; Specialist Centre for Kidney Cancer, Department of Urology, Royal Free London NHS Foundation Trust, London, UK.; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Renal Cancer Network, Amsterdam, The Netherlands.; Division of Surgery and Interventional Science, University College London, London, UK.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101771568 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-1683 (Electronic) Linking ISSN: 26661683 NLM ISO Abbreviation: Eur Urol Open Sci Subsets: PubMed not MEDLINE

Breukers SE; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Traets JJH; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van Dijk SW; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Ostos MM; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Fraterman I; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Crommelin RD; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van der Hulst H; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Qiao X; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Boere T; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van de Poll-Franse LV; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Retèl V; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.; van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Vos JL; Head and Neck Service and Immunogenomic Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Toppenberg AGL; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van der Heijden M; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Missale F; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Balm F; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van den Brekel M; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Dirven R; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Karakullukcu MB; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Karssemakers L; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Klop WMC; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Lohuis PJFM; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Schreuder WH; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Maxillofacial Surgery, Amsterdam University Medical Center, Amsterdam, The Netherlands.; Smeele LE; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Maxillofacial Surgery, Amsterdam University Medical Center, Amsterdam, The Netherlands.; van der Velden LA; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Plasmeijer E; Department of Dermatology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Smit LA; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; de Boer JP; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Navran A; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Westerink B; Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; de Koekkoek-Doll PK; Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Castelijns J; Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Wondergem M; Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Vogel WV; Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Kuijpers A; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van Houdt WJ; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Onderwater S; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Maas-Bannink E; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Cornelissen S; Core Facility Molecular Pathology & Biobanking, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Broeks A; Core Facility Molecular Pathology & Biobanking, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Tijink BM; Department of Head and Neck Surgery & Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; Devriese LA; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; de Bree R; Department of Head and Neck Surgery & Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; Blank CU; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Hematology and Oncology, University Clinic Regensburg (UKR), Regensburg, Germany.; Schumacher TN; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.; Thommen DS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Haanen JBAG; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Zuur CL; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. c.zuur@nki.nl.; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands. c.zuur@nki.nl.; Department of Otorhinolaryngology, Head and Neck Surgery, Leiden University Medical Center, Leiden, The Netherlands. c.zuur@nki.nl.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Tan PB; Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verschoor YL; Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; van den Berg JG; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Balduzzi S; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Kok NFM; Department of Surgery, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Ijsselsteijn ME; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.; Moore K; Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Jurdi A; Natera Inc, Austin, TX, USA.; Tin A; Natera Inc, Austin, TX, USA.; Kaptein P; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; van Leerdam ME; Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.; Haanen JBAG; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Voest EE; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; de Miranda NFCC; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.; Schumacher TN; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands.; Wessels LFA; Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Chalabi M; Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. m.chalabi@nki.nl.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. m.chalabi@nki.nl.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

Schuiveling M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; van Duin IAJ; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Ter Maat LS; Image Sciences Institute, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; van der Weerd JC; Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.; Verheijden RJ; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; van den Berkmortel F; Department of Medical Oncology, Zuyderland Medical Center Sittard, Sittard-Geleen, the Netherlands.; Blank CU; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Breimer GE; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Burgers FH; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Boers-Sonderen M; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.; de Groot JWB; Isala Oncology Center, Isala Hospital, Zwolle, the Netherlands.; Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Division of Molecular Oncology and Immunology, Oncode Institute, Amsterdam, the Netherlands.; Melanoma Clinic, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.; Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, the Netherlands.; Vreugdenhil G; Department of Internal Medicine, Maxima Medical Center, Eindhoven, the Netherlands.; Westgeest H; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands.; Schrader AMR; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.; Pluim JPW; Medical Image Analysis, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands.; van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Veta M; Medical Image Analysis, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands.; Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Blokx WAM; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

van der Geest D; Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands d.vd.geest@nki.nl.; van Vliet A; Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Peeper DS; Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Haanen JBAG; Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Smit EF; Pulmonary Diseases, LUMC, Leiden, The Netherlands.; Theelen WSME; Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Bloem M; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Centre, Einthovenweg 20, Leiden 2333ZC, the Netherlands; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands. Electronic address: m.bloem@lumc.nl.; van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, De Boelelaan 1118, Amsterdam 1081HZ, the Netherlands.; Haanen JBAG; Department of Medical Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, Leiden 2333ZA, the Netherlands.; Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, P. Debyelaan 25, Maastricht 6229 HX, the Netherlands.; van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Centre Sittard, Dr. H. van der Hoffplein 1, Sittard-Geleen 6162BG, the Netherlands.; Blank CU; Department of Medical Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands.; Blokx WAM; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584CX, the Netherlands.; Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, Nijmegen 6525GA, the Netherlands.; Boreel CDM; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584CX, the Netherlands.; de Groot JWB; Isala Oncology Center, Isala, Dokter van Heesweg 2, Zwolle 8025AB, the Netherlands.; Hospers GAP; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, Groningen 9713GZ, the Netherlands.; Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, Leiden 2333ZA, the Netherlands.; Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Koningsplein 1, Enschede 7512KZ, the Netherlands.; Rikhof B; Department of Internal Medicine, Medical Centre Leeuwarden, Henri Dunantweg 2, Leeuwarden 8934AD, the Netherlands.; Simkens LHJ; Department of Internal Medicine, Maxima Medical Centre, De Run 4600, Eindhoven 5504DB, the Netherlands.; Stevense-den Boer AM; Department of Internal Medicine, Amphia Hospital, Molengracht 21, Breda 4818CK, the Netherlands.; van der Veldt AAM; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Centre, 's-Gravendijkwal 230, Rotterdam 3015CE, the Netherlands.; Wouters MWJM; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Centre, Einthovenweg 20, Leiden 2333ZC, the Netherlands; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands.; Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584CX, the Netherlands.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Borgers JSW; Department of Medical Oncology, Netherlands Cancer Institute, the Netherlands.; Johnson DB; Department of Medicine, Vanderbilt University Medical Center, TN, USA.; Livingstone E; Department of Dermatology, University Hospital Essen, Germany.; The German Cancer Consortium, Campus Essen, Germany.; National Center for Tumor Diseases (NCT-West), Campus Essen & Research Alliance Ruhr, Research Center One Health, Campus Essen, Germany.; Schadendorf D; Department of Dermatology, University Hospital Essen, Germany.; The German Cancer Consortium, Campus Essen, Germany.; National Center for Tumor Diseases (NCT-West), Campus Essen & Research Alliance Ruhr, Research Center One Health, Campus Essen, Germany.; Buchbinder EI; Department of Medical Oncology, Dana Farber Cancer Institute, MA, USA.; Haydu LE; Department of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, Jacksonville, FL, USA.; Gohil L; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Robinson WA; Center for Rare Melanomas, CU Anschutz Medical Center, CO, USA.; Mehmi I; Department of Hematology Oncology, The Angeles Clinic and Research Institute, Cedar Sinai Affiliate, CA, USA.; Hamid O; Department of Hematology Oncology, The Angeles Clinic and Research Institute, Cedar Sinai Affiliate, CA, USA.; Ferreira M; Department of Medicine, Duke University, NC, USA.; Salama AKS; Department of Medicine, Duke University, NC, USA.; Dimitriou F; Department of Dermatology, University Hospital of Zurich, Switzerland.; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Carlino MS; Department of Medical Oncology, Melanoma Institute Australia, The University of Sydney, Australia.; Long GV; Department of Medical Oncology, Melanoma Institute Australia, The University of Sydney, Australia.; Faculty of Medicine & Health, The University of Sydney, Australia.; Charles Perkins Centre, The University of Sydney, Australia.; Royal North Shore & Mater Hospitals, Australia.; Ascierto PA; Department of Melanoma, Istituto Nazionale Tumori Fondazione G, Pascale, Italy.; Simeone E; Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori Fondazione G, Pascale, Italy.; Najjar YG; Department of Hematology/Oncology, University of Pittsburgh Medical Center, PA, USA.; Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands.; Choi J; Department of Medicine, Division of Hematology and Oncology, Northwestern University, IL, USA.; Chandra S; Department of Medicine, Division of Hematology and Oncology, Northwestern University, IL, USA.; Wayne JD; Division of Surgical Oncology, Northwestern Memorial Hospital, IL, USA.; García CIR; Department of Medical Oncology, Centro de Investigación Clínica Bradford Hill, Chile.; Xu W; Department of Medical Oncology, Princess Alexandra Hospital, Brisbane, Australia.; University of Queensland, Brisbane, Australia.; Lebbé C; Department of Dermatology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, France.; Da-Meda L; Department of Dermatology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, France.; Atkinson V; Department of Medical Oncology, Princess Alexandra Hospital, Australia.; Mckean M; Sarah Cannon Research Institute, Tennessee Oncology, TN, USA.; Forschner A; Department of Dermatology, Eberhard Karls University of Tuebingen, Germany.; Asare EA; Department of Surgery, University of Utah, Huntsman Cancer Institute, UT, USA.; Daletzakis A; Department of Biometrics, Netherlands Cancer Institute, the Netherlands.; Taylor JS; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Amant F; Department of Gynecology, Netherlands Cancer Institute, the Netherlands.; Division of Gynecologic Oncology, UZ Leuven, Belgium.; Tsai KK; Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, USA.; Eroglu Z; Department of Cutaneous Oncology, Moffitt Cancer Center, FL, USA.; Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute, the Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Melanoma Clinic, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Glitza de Oliva IC; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE

Ten Ham RMT; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Epidemiology & Health Economics, Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht, The Netherlands.; Rohaan MW; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Egeler M; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Menezes R; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Holz Borch T; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark.; Kessels R; Division of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Jedema I; Biotherapeutics Unit, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Nuijen B; Division of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Nijenhuis CM; Division of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van de Poll-Franse LV; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Geukes Foppen MH; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Lindenberg M; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Mansfield Noringriis I; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark.; Monberg TJ; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark.; Donia M; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark.; van Harten W; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Svane IM; Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark.; Haanen JBAG; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Retèl VP; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands. Electronic address: v.retel@nki.nl.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Burgers FH; Division of Medical Oncology, Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands.; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands.; van der Mijn JCK; Division of Medical Oncology, Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands.; Seijkens TTP; Division of Medical Oncology, Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands.; Jedema I; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands.; Bex A; Department of Urology, Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands.; Department of Urology, The Royal Free London NHS Foundation Trust, London, UK.; University College London Division of Surgery and Interventional Science, London, UK.; Haanen JBAG; Division of Medical Oncology, Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands. j.haanen@nki.nl.; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands. j.haanen@nki.nl.; Department of Medical Oncology, Leiden University Medical Centre (LUMC), Leiden, the Netherlands. j.haanen@nki.nl.; Head of Melanoma Clinic, Lausanne University Hospital (CHUV), Lausanne, Switzerland. j.haanen@nki.nl.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500081 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-507X (Electronic) Linking ISSN: 17595061 NLM ISO Abbreviation: Nat Rev Nephrol Subsets: MEDLINE

Egeler MD; Department of Psychosocial Oncology and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: m.egeler@nki.nl.; Klobuch S; Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, the Netherlands.; Tak WS; Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, the Netherlands.; Rohaan MW; Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, the Netherlands; Netherlands Cancer Institute, Division of Radiotherapy, Amsterdam, the Netherlands.; Borch TH; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Noringriis IM; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Tissier R; Department of Epidemiology and Biostatistics, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Lucas MW; Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, the Netherlands.; van Houdt W; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; van Akkooi ACJ; Melanoma Institute Australia, Wollstonecraft, Sydney, NSW, Australia; University of Sydney, Faculty of Medicine and Health, Camperdown, NSW, Australia; Royal Prince Alfred Hospital, Institute of Academic Surgery, Camperdown, NSW, Australia.; Jedema I; Netherlands Cancer Institute, Division of Molecular Oncology and Immunology, Amsterdam, the Netherlands.; Donia M; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Blank CU; Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, the Netherlands; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands; Department Hematology and Oncology, University Clinic Regensburg (UKR), Germany.; Svane IM; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.; Haanen JBAG; Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, the Netherlands; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands; Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; van de Poll-Franse LV; Department of Psychosocial Oncology and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical and Clinical Psychology, Center of Research on Psychological and Somatic Disorders (CoRPS), Tilburg University, Tilburg, the Netherlands.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

de Groot S; Institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, The Netherlands.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, The Netherlands.; Blommestein HM; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, The Netherlands.; Leeneman B; Institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, The Netherlands.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, The Netherlands.; Uyl-de Groot CA; Institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, The Netherlands.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, The Netherlands.; Haanen JBAG; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Wouters MWJM; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.; Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands.; van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Center Sittard, Sittard-Geleen, The Netherlands.; Blokx WAM; Department of Pathology, Division of Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.; Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.; de Groot JWB; Isala Oncology Center, Isala, Zwolle, The Netherlands.; Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; van Not OJ; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; van der Veldt AAM; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.; Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; van Baal PHM; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, The Netherlands.

Publisher: Sage Publications Country of Publication: United States NLM ID: 8109073 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-681X (Electronic) Linking ISSN: 0272989X NLM ISO Abbreviation: Med Decis Making Subsets: MEDLINE